期刊文献+

肺动脉高压药物治疗新进展 被引量:1

下载PDF
导出
摘要 肺动脉高压以肺小动脉收缩、血管增生与重构为主要特征,引起肺血管阻力进行性升高,导致右心功能衰竭。对肺动脉高压的治疗从过去非特异性血管扩张药物到现在靶向药物,从单一药物治疗到多药物联合以及综合治疗,极大地改善了患者的症状及预后。该文就当前肺动脉高压药物治疗理念作一介绍。
出处 《国际心血管病杂志》 2014年第4期256-258,267,共4页 International Journal of Cardiovascular Disease
基金 上海市科学技术委员会科研计划项目(13ZR1409000) 长海医院"1255"转化医学项目(CH125550200)
  • 相关文献

参考文献24

  • 1Betkier-Lipinska K, Ryczek R, Kwasiborski P, et al. Pulmonary arterial hypertension modern diagnostics and therapy--Part 1 [J]. Pol Merkur Lekarski, 2013, 34(204) :355-359.
  • 2Judge EP, Gaine SP. Management o pulmonary arterial hypertension[J]. Curr Opin Crit Care, 2013, 19(1) :44-50.
  • 3Thomas IC, Glassner-Kolmin C, Gomberg-Maitland M. Long- term effects of continuous prostacyclin therapy in adults with pulmonary hypertension associated with congenital heart disease[J]. Int J Cardiol, 2013, 32(9) 889-896.
  • 4Cabrol S, Souza R, Jais X, et al. Intravenous epoprostenol in inoperable chronic thromboembolic pulmonary hypertension [J]. J Heart Lung Transplant, 2007, 26(4) : 357-362.
  • 5Benza RL, Tapson VF, Gomberg-Maitland M, et al. One- year experience with intravenous treprostinil for pulmonary arterial hypertension[J]. J Heart Lung Transplant, 2013, 32 (9) :889-896.
  • 6McLaughlin VV, Benza RL, Rubin LJ, et al. Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension., a randomized controlled clinical trial[J]. J Am Coil Cardiol, 2010, 55(18) : 1915-1922.
  • 7Lopez-Meseguer M, Berastegui C, Monforte V, et al. Inhaled iloprost plus oral sildenafil in patients with severe pulmonary arterial hypertension delays the need for lung transplantation[J]. Transplant Proc, 2013, 45(6).. 2347-2350.
  • 8Olschewski H, Simonneau G, Galie N, et al. Inhaled iloprost for severe pulmonary hypertension[J]. N Engl J Med, 2002, 347(5) : 322-329.
  • 9Humbert M, Sitbon O, Simonneau G. Treatment of pulmonary arterial hypertension[J]. N Engl J Med, 2004, 351 (14): 1425 1436.
  • 10Galie N, Rubin L, Hoeper M, et al. Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study), a double-blind, randomised controlled trial[J]. Lancet, 2008, 371(9630): 2093-2100.

同被引文献13

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部